Effect of biologic agents and inflammation on lipid levels and cardiovascular risk in rheumatoid arthritis patients.
Dimitrios A PappasGeorge ReedKevin KaneJeffrey R CurtisChristina Charles-SchoemanJon T GilesJoel M Kremer
Published in: Seminars in arthritis and rheumatism (2024)
Moderate increases in lipid levels on bDMARD treatment were not associated with an increased CVD risk by RRS regardless of the bDMARD initiated. Changes in CRP were significantly associated with changes in lipids in a mediator analysis.